Efficacy of Blue-CARBA Test for Detection of Carbapenemase in Acinetobacter baumannii Isolated from Burn Patients
Abstract
Background: Resistance to carbapenem as a most effective antibiotic for treatment of Acinetobacter baumannii infection can make a complication in treatment of patients. Several phenotypic methods have been introduced for detection of the carbapenemase producing strains. The aim of this study was determined the efficacy of the newest method that is called Blue-CARBA test for identification of the carbapenemase producing Acinetobacter baumannii.
Methods: In this cross sectional study 63 Acinetobacter baumannii have been collected from burn wounds infection. Carbapenem susceptibility testing has been conducted by disc diffusion agar method after identification The Modified Hodge test and Blue-CARBA test was performed for all carbapenem resistant strains. Vim, imp, oxa-23, oxa-48, NDM-1, SPM-1 and kpc genes have been detected as a most common carbapenemase in Acinetobacter baumannii.
Results: Sequence analysis showed that 54 isolates include oxa-23 gene. Eight and 5 strains carried vim and kpc genes respectively. MHT and Blue-CARBA test were positive in 27 and 28 of imipenem resistant strains, respectively.
Conclusion: According to the results of this study, Blue-CARBA test showed similar power of carbapenemase producing identification with Modified Hodge test and can be purposed use in place of MHT for detection of carbapenemase.
2. Azimi L, Lari AR, Talebi M, et al. Comparison between phenotypic and PCR for detection of OXA-23 type and metallo-beta-lactamases producer Acinetobacter spp. GMS HIC 2013; 8(2):6.
3. Azimi L, Talebi M, Khodaei F, et al. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of carbapenemases producing Acinetobacter baumannii isolated from burn patients. Burns 2016; 42(2):441-5.
4. Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol 2012; 35(3):317-25.
5. Ardebili A, Talebi M, Azimi L, et al. Effect of efflux pump inhibitor carbonyl cyanide 3-chlorophenylhydrazone on the minimum inhibitory concentration of ciprofloxacin in Acinetobacter baumannii clinical isolates. Jundishapur J Microbiol 2014; 7(1):5.
6. Azimi L, Talebi M, Pourshafie MR, et al. Characterization of carbapenemases in extensively drug resistance Acinetobacter baumannii in a burn care center in Iran. Int J Mol Cell Med 2015; 4(1):46.
7. Owlia P, Azimi L, Gholami A, et al. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Infez Med 2012; 20(3):182-7.
8. Azimi L, Lari AR, Alaghehbandan R, et al. KPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran. Ann. Burns Fire Disasters 2012; 25(2):74.
9. Lari AR, Azimi L, Rahbar M, et al. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns 2013; 39(1):174-6.
10. Sousa D, Castelo-Corral L, Gutiérrez-Urbón JM, et al. Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology? J Antimicrob Chemotherapy 2013; 68(8):1917-25.
11. Soleymanzadeh-Moghadam S, Azimi L, Amani L, et al. Analysis of antibiotic consumption in burn patients. GMS HIC 2015; 9(10):1-5.
12. Karuniawati A, Saharman YR, Lestari DC. Detection of carbapenemase encoding genes in Enterobacteriace, Pseudomonas aeruginosa, and Acinetobacter baumanii isolated from patients at Intensive Care Unit Cipto Mangunkusumo Hospital in 2011. Acta Med Indones 2013; 45(2):101-6.
13. Pires J, Novais A, Peixe L. Blue-carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures. J Clin Microbiol 2013; 51(12):4281-3.
14. Clinical, Institute LS. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute Wayne, PA; 2020.
15. Pasteran F, Veliz O, Ceriana P, et al. Evaluation of the Blue-Carba test for rapid detection of carbapenemases in gram-negative bacilli. J Clin Microbiol 2015; 53(6):1996-8.
16. Zhao C, Xie W, Zhang W, et al. Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro. Chinese J Burns 2014; 30(2):166-70.
17. Pasteran F, Veliz O, Faccone D, et al. A simple test for the detection of KPC and metallo‐β‐lactamase carbapenemase‐producing Pseudomonas aeruginosa isolates with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infec 2011; 17(9):1438-41.
18. Poorabbas B, Mardaneh J, Rezaei Z, et al. Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran. Iranian J Microbiol 2015; 7(3):127.
19. Razavi Nikoo H, Ardebili A, Mardaneh J. Systematic review of antimicrobial resistance of clinical Acinetobacter baumannii isolates in Iran: an update. Microb Drug Resist 2017; 23(6):744-56.
20. Soltani J, Poorabbas B, Miri N, et al. Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran. World J Clin Cases 2016; 4(3):63.
21. Liu S, Wang Y, Xu J, et al. Genome sequence of an OXA23-producing, carbapenem-resistant Acinetobacter baumannii strain of sequence type ST75. Am Soc Microbiol 2012; 194:6000-1.
22. Wolter DJ, Khalaf N, Robledo IE, et al. Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican medical center hospitals: dissemination of KPC and IMP-18 β-lactamases. Antimicrob Agent Chemother 2009; 53(4):1660-4.
Files | ||
Issue | Vol 13 No 1 (2025) | |
Section | Original Articles | |
DOI | https://doi.org/10.18502/jmb.v13i1.18045 | |
Keywords | ||
Acinetobacter baumannii Blue-CARBA test Carbapenemase Modified hodge test. |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |